Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | CETP | P11597 | 3/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL206609 | 0.91 | TSHR (0.68) | TSHRCETPELANEIDO1SRC | |
| SCHEMBL28555680 | 0.89 | TSHR (0.61) | TSHRCETPELANESRCPDPK1 | |
| SCHEMBL10408383 | 0.88 | TSHR (0.66) | TSHRCETPELANESRCPDPK1 | |
| SCHEMBL10200001 | 0.88 | TSHR (0.55) | TSHRCETPELANEIDO1SRC | |
| SCHEMBL6749263 | 0.86 | TSHR (0.75) | TSHRCETPELANESRCPDPK1 | |
| SCHEMBL5379773 | 0.84 | TSHR (0.61) | TSHRCETPELANEIDO1SRC | |
| SCHEMBL11624100 | 0.84 | TSHR (0.47) | TSHRCETPELANEIDO1SRC | |
| SCHEMBL991032 | 0.83 | TSHR (0.59) | TSHRCETPELANEIDO1SRC | |
| SCHEMBL15689772 | 0.83 | TSHR (0.59) | TSHRCETPELANEIDO1SRC | |
| SCHEMBL20123381 | 0.83 | TSHR (0.59) | TSHRCETPELANEIDO1SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 866 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116902-A1 | NOVEL COMPOUND AS FUNCTIONAL ANTAGONIST FOR S1PR1 AND S1PR4 | NEXTGEN BIOSCIENCE CO., LTD. (KR) | 2026-04-30 | — | — | US | claimed |
| US-20250320240-A1 | SCALABLE METHODS OF MANUFACTURING PSILOCYBIN | COMPASS PATHFINDER LTD (GB) | 2025-10-16 | — | — | US | claimed |
| WO-2025215243-A1 | SCALABLE METHODS OF MANUFACTURING PSILOCYBIN | COMPASS PATHFINDER LIMITED (GB) | 2025-10-16 | — | — | WO | claimed |
| WO-2025107822-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL AND PREPARATION METHOD THEREFOR, BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2025-05-30 | — | — | WO | claimed |
| CN-120048867-A | Positive electrode active material, preparation method thereof, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-114380859-B | Preparation method of dibenzyl phosphate and tetrabenzyl pyrophosphate | 威智医药股份有限公司 | 2024-11-01 | — | — | CN | claimed |
| US-20240199660-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | COMPASS PATHFINDER LIMITED (GB) | 2024-06-20 | — | — | US | claimed |
| CN-113603721-B | Method for synthesizing SAICAR | 重庆文理学院 | 2023-12-01 | — | — | CN | claimed |
| CN-113583044-B | Preparation method of medicine for preventing chemotherapy-related nausea and vomiting | 山东罗欣药业集团股份有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-11505564-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | COMPASS PATHFINDER LIMITED (GB) | 2022-11-22 | — | — | US | claimed |
| JP-2001508428-A | — | — | 2001-06-26 | — | — | JP | claimed |
| EP-0948504-A1 | PREPARATION OF CYANOPHOSPHONATES FROM PYROPHOSPHATES AND CYANIDE | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | claimed |
| US-5859278-A | Method for preparing cyanophosphonate derivatives from pyrophosphate or polyphosphate esters and cyanide | MONSANTO COMPANY (US) | 1999-01-12 | — | — | US | claimed |
| WO-1998029420-A1 | PREPARATION OF CYANOPHOSPHONATES FROM PYROPHOSPHATES AND CYANIDE | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | claimed |
| US-5292913-A | Labeling with deuterium or tritium | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1994-03-08 | — | — | US | claimed |
| EP-0583698-A2 | Deoxycyclitol derivatives, process for their preparation and their use in medicaments | Bayer Pharma (FR) | 1994-02-23 | — | — | EP | claimed |
| US-5233023-A | Phosphorylating with tetrabenzyl pyrophosphate, debenzylating by hydrogenolysis | MERCK & CO., INC. (US) | 1993-08-03 | — | — | US | claimed |
| EP-0525889-A1 | Process for phosphate ester compounds of certain cyclohexapeptides | MERCK & CO. INC. (US) | 1993-02-03 | — | — | EP | claimed |
| EP-0262227-B1 | PROCESS FOR THE PREPARATION OF MYOINOSITOL DERIVATIVES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-01-20 | — | — | EP | claimed |
| EP-0262227-A1 | Process for the preparation of myoinositol derivatives | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1988-04-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116902-A1 | NOVEL COMPOUND AS FUNCTIONAL ANTAGONIST FOR S1PR1 AND S1PR4 | S1PR1, S1PR4, S1PR3 | TSHR 843/4885CETP 667/4885ELANE 4402/4885 |
| US-11505564-B2 | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | HTR1B, HTR2B, HTR5A | TSHR 4817/4885CETP 604/4885ELANE 4859/4885 |
| US-20250320240-A1 | SCALABLE METHODS OF MANUFACTURING PSILOCYBIN | HTR3C, HTR4, UGT8 | TSHR 2837/4885CETP 2106/4885ELANE 4743/4885 |
| US-20240199660-A1 | PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE | HTR1B, HTR2B, HTR5A | TSHR 4817/4885CETP 604/4885ELANE 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.